Conformis IP Buys Time for New Products

Conformis reported 2Q21 orthopedic revenue of $56.3 million, +184.4% vs. 2Q20. The company expects royalty revenue to comprise roughly 1% of its quarterly revenue, but in the second quarter, it accounted for 73% or $41 million. Virtually the entire amount came from one-time payments including the final milestone payment from Stryker for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us